Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. PRYMY
5. SKA-B
6. PBA
7. CCH:LN
8. META
9. BAJAJHFL:I
10. CCHGY

Go back to Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update

Achieve Life Sciences (ACHV) Tops Q4 EPS by 9c

March 14, 2019 4:17 PM EDT

Achieve Life Sciences (NASDAQ: ACHV) reported Q4 EPS of ($0.55), $0.09 better than the analyst estimate of ($0.64).

Recent highlights:

Completion of enrollment in 254-subject Phase 2b ORCA-1 trial of cytisinicline in U.S. smokersPresented final data from cytisinicline Phase 1/2 multi-dose,... More